Abbott raises 2022 profit forecast

(Reuters) - Abbott Laboratories on Wednesday raised its annual earnings forecast following strong demand for its medical devices and diagnostics products.

The company now expects at least $4.90 per share in adjusted earnings in 2022, compared with at least $4.70 forecast earlier.

(Reporting by Leroy Leo and Amruta Khandekar in Bengaluru; Editing by Maju Samuel and Sriraj kalluvila)